In Medicare Bill, HMOs Got What They Wanted

When the dust cleared over how $35 billion in Medicare "givebacks" would be divided, the Republicans prevailed — Medicare HMOs got a bigger cut than Democrats wanted to give them. Now, President Bush may be poised to give Medicare managed care plans more.

The bill overwhelmingly passed a lame-duck Congress eager to go home — 79 members were absent at the vote. The measure, signed by then-President Clinton, restores $11 billion each to health plans and hospitals over five years, expands benefits, and increases payment rates for some procedures. The bill promises additional funds to health plans if Congress mandates new Medicare benefits. Karen Ignagni, president of the American Association of Health Plans, called the law a step toward preventing the "full-scale collapse" of Medicare+Choice.

Health plans may have even more reason to be optimistic. Before the election, Bush avoided the HMO-bashing of the Gore campaign that, in essence, made it difficult for Congressional Democrats to openly support higher payments to Medicare+Choice plans. Now, some observers say, Bush may be favorably inclined to further payment increases for health plans.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to or online at

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.